|
Volumn 28, Issue 2, 2008, Pages 144-150
|
Antidepressant drug use and risk of venous thromboembolism
|
Author keywords
Amitriptyline; Antidepressants; Risk; Venous thromboembolism
|
Indexed keywords
AMITRIPTYLINE;
AMOXAPINE;
ANTIDEPRESSANT AGENT;
CITALOPRAM;
CLOMIPRAMINE;
DESIPRAMINE;
DOSULEPIN;
DOXEPIN;
FLUOXETINE;
FLUPENTIXOL;
FLUVOXAMINE;
IMIPRAMINE;
LOFEPRAMINE;
MAPROTILINE;
MIANSERIN;
MIRTAZAPINE;
MOCLOBEMIDE;
MONOAMINE OXIDASE A INHIBITOR;
NEFAZODONE;
NORTRIPTYLINE;
PAROXETINE;
PHENELZINE;
PROTRIPTYLINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRANYLCYPROMINE;
TRAZODONE;
TRICYCLIC ANTIDEPRESSANT AGENT;
TRIMIPRAMINE;
ADULT;
AGED;
ARTICLE;
BODY MASS;
CASE CONTROL STUDY;
COMORBIDITY;
CONTROLLED STUDY;
DEPRESSION;
DRUG USE;
FEMALE;
GENERAL PRACTICE;
GROUPS BY AGE;
HORMONE SUBSTITUTION;
HUMAN;
HYPERTENSION;
MAJOR CLINICAL STUDY;
MALE;
RISK;
SMOKING;
STATISTICAL ANALYSIS;
UNITED KINGDOM;
VENOUS THROMBOEMBOLISM;
ADULT;
AGED;
AMITRIPTYLINE;
ANTIDEPRESSIVE AGENTS;
CASE-CONTROL STUDIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
LOGISTIC MODELS;
MALE;
MIDDLE AGED;
VENOUS THROMBOEMBOLISM;
|
EID: 38849190673
PISSN: 02770008
EISSN: None
Source Type: Journal
DOI: 10.1592/phco.28.2.144 Document Type: Article |
Times cited : (23)
|
References (7)
|